Annual report pursuant to section 13 and 15(d)

Summary of Significant Accounting Policies (Details Textual)

v2.4.0.6
Summary of Significant Accounting Policies (Details Textual) (USD $)
 1 Months Ended 12 Months Ended 12 Months Ended 12 Months Ended
Oct. 31, 2012
Dec. 31, 2012
Segment
Payor
FinancialInstitution
Dec. 31, 2011
Feb. 16, 2010
Dec. 31, 2012
Interest Rate Swap [Member]
Dec. 31, 2011
Interest Rate Swap [Member]
Dec. 31, 2011
Warrant [Member]
Feb. 16, 2010
Warrant [Member]
May 27, 2011
2007 Stock Incentive Plan [Member]
Dec. 31, 2007
2007 Stock Incentive Plan [Member]
Dec. 31, 2012
Medicare [Member]
Dec. 31, 2011
Medicare [Member]
Dec. 31, 2012
Blue Cross/Blue Shield affiliates [Member]
Dec. 31, 2011
Blue Cross/Blue Shield affiliates [Member]
Dec. 31, 2012
Physician and customer relationships [Member]
Dec. 31, 2012
Noncompete Agreements [Member]
Dec. 31, 2012
Software [Member]
Dec. 31, 2012
Computers Equipment and Software [Member]
Dec. 31, 2012
Maximum [Member]
Dec. 31, 2012
Minimum [Member]
Dec. 31, 2012
Restricted Stock [Member]
Dec. 31, 2011
Restricted Stock [Member]
Summary of Significant Accounting Policies (Textual) [Abstract]                                            
Estimated useful lives                                   3 years 7 years 3 years    
Physician and customer relationships useful life Period                             15 years 5 years 3 years          
Impairment of indefinite-lived assets $ 0                                          
Gross billings for ambulatory infusion pump services                     31.00% 31.00% 18.00% 21.00%                
Maximum number of share issued in connection with the grant of stock-based or stock-denominated award                   2,000,000                        
Additional share issued under stock incentive plan                 3,000,000                          
Outstanding Warrants               35,100,000                            
Share based compensation expense   900,000 1,200,000                                      
Company's new debt agreement         200,000 15,600,000                                
Unvested restricted shares with anti-dilutive effect   300,000                                     200,000 2,600,000
Gain on derivatives     83,000       100,000                              
Summary of Significant Accounting Policies (Additional Textual) [Abstract]                                            
Proceeds from operating activities and the use of proceeds by investing activities     400,000                                      
Reclassification of inventory to Medical equipment held for sale or rental     1,900,000                                      
Number operating Business segments   1                                        
Liquid investments with original maturities period   three months or less                                        
Maintenance of cash and cash equivalents with number of financial institutions   2                                        
Estimated obsolete inventory   200,000 200,000                                      
Medical equipment in rental services useful life   5 years                                        
Medical equipment held for sale or rental reserves   100,000 0                                      
Non-cash charges in property and equipment and inventory     1,400,000                                      
Goodwill   0 0                                      
Accumulated other comprehensive loss     $ (136,000)                                      
Number of payors having greater than 7% of the Company's revenue   0                                        
Maximum Percentage of revenue of specified payors   7.00%                                        
Common stock exercise price   5.00                                        
Remaining warrants that existed after the exchange       9,400,000